{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T17:36:35Z","timestamp":1758044195906,"version":"3.44.0"},"reference-count":13,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"unspecified","delay-in-days":73,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Neurol Open"],"accepted":{"date-parts":[[2025,8,10]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:p>\n                  <jats:bold>Background:<\/jats:bold> Multiple Sclerosis is a chronic inflamatory disorder. The prevalence of hyperprolactinemia in patient with MS is 6.7 %. <jats:bold>Method:<\/jats:bold> Case report. <jats:bold>Result:<\/jats:bold> This case report describes a 31-year-old woman with multiple sclerosis (MS) who presented with galactorrhea, a rare symptom of MS, along with other neurological manifestations. She had elevated serum prolactin levels and a normal-sized pituitary gland with no evidence of adenoma or lesions. The elevated serum prolactin levels were normalized after treatment with intravenous methylprednisolone. No dopaminergic drugs were used to treat her galactorrhea, which also resolved after receiving intravenous methylprednisolone. <jats:bold>Conclusion:<\/jats:bold> This case illustrates the possible association between MS and hyperprolactinaemia and if the etiology is MS there is no need for treatment of hyperprolactinemia.<\/jats:p>","DOI":"10.1136\/bmjno-2024-000971","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T10:55:17Z","timestamp":1757674517000},"page":"e000971","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Hyperprolactinemia as a manifestation of multiple sclerosis attack"],"prefix":"10.1136","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0212-4886","authenticated-orcid":false,"given":"Sahand","family":"Golparvar","sequence":"first","affiliation":[{"name":"Department of Neurology, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saba","family":"Naghavi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Isfahan University of Medical Sciences, Isfahan, Iran"},{"name":"Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iman","family":"Adibi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Isfahan University of Medical Sciences, Isfahan, Iran"},{"name":"Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,9,12]]},"reference":[{"key":"2025091203551338000_7.2.e000971.1","unstructured":"Al-Chalabi M , Bass AN , Prolactin AIP . Physiology prolactin. Treasure Island (FL): StatPearls Publishing, 2022."},{"key":"2025091203551338000_7.2.e000971.2","first-page":"91","article-title":"Ferritin and prolactin levels in multiple sclerosis","volume":"13","author":"Da Costa","year":"2011","journal-title":"Isr Med Assoc J"},{"key":"2025091203551338000_7.2.e000971.3","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(91)90094-N"},{"key":"2025091203551338000_7.2.e000971.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2011.07.032"},{"key":"2025091203551338000_7.2.e000971.5","doi-asserted-by":"publisher","DOI":"10.1177\/1352458512458555"},{"key":"2025091203551338000_7.2.e000971.6","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30470-2"},{"key":"2025091203551338000_7.2.e000971.7","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-009-0076-1"},{"key":"2025091203551338000_7.2.e000971.8","unstructured":"Mbaba A , Ogolodom M , Abam R , et al . Pituitary Adenoma, Multiple Sclerosis, and Visual Impairment: How are they Related? A Case Report. J Med Case Rep 2019;670."},{"key":"2025091203551338000_7.2.e000971.9","first-page":"268","article-title":"Hyperprolactinemia and galactorrhea with duloxetine in neuropathic pain management","volume":"33","author":"Derle","year":"2021","journal-title":"Agri"},{"key":"2025091203551338000_7.2.e000971.10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17122026","article-title":"Prolactin: Friend or Foe in Central Nervous System Autoimmune Inflammation?","volume":"17","author":"Costanza","year":"2016","journal-title":"Int J Mol Sci"},{"key":"2025091203551338000_7.2.e000971.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.11.005"},{"key":"2025091203551338000_7.2.e000971.12","doi-asserted-by":"crossref","unstructured":"Hodge M , Ganta VA , Nunlee-Bland GL , et al . MON-258 Hyperprolactinemia: An Unusual Initial Presenting Manifestation of Multiple Sclerosis. J Endocr Soc 2020;4. doi:10.1210\/jendso\/bvaa046.1495","DOI":"10.1210\/jendso\/bvaa046.1495"},{"key":"2025091203551338000_7.2.e000971.13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.5152\/npa.2016.16979","article-title":"Serum Prolactin Levels in Multiple Sclerosis, Neuromyelitis Optica, and Clinically Isolated Syndrome Patients","volume":"53","author":"Turkoglu","year":"2016","journal-title":"Arch Neuropsychiatr"}],"container-title":["BMJ Neurology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjno-2024-000971","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T10:55:21Z","timestamp":1757674521000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurologyopen.bmj.com\/lookup\/doi\/10.1136\/bmjno-2024-000971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":13,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,9,12]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/bmjno-2024-000971"],"URL":"https:\/\/doi.org\/10.1136\/bmjno-2024-000971","relation":{},"ISSN":["2632-6140"],"issn-type":[{"value":"2632-6140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}